Acute respiratory distress syndrome (ARDS) as an adverse event following immunization: Case definition & guidelines for data collection, analysis, and presentation of immunization safety data
- PMID: 33583673
- PMCID: PMC7843093
- DOI: 10.1016/j.vaccine.2021.01.053
Acute respiratory distress syndrome (ARDS) as an adverse event following immunization: Case definition & guidelines for data collection, analysis, and presentation of immunization safety data
Abstract
This is a Brighton Collaboration Case Definition of the term "Acute Respiratory Distress Syndrome - ARDS" to be utilized in the evaluation of adverse events following immunization. The Case Definition was developed by a group of experts convened by the Coalition for Epidemic Preparedness Innovations (CEPI) in the context of active development of vaccines for SARS-CoV-2 vaccines and other emerging pathogens. The case definition format of the Brighton Collaboration was followed to develop a consensus definition and defined levels of certainty, after an exhaustive review of the literature and expert consultation. The document underwent peer review by the Brighton Collaboration Network and by selected Expert Reviewers prior to submission. The comments of the reviewers were taken into consideration and edits incorporated in this final manuscript.
Keywords: ARDS; Acute respiratory distress syndrome; Adult; Adverse event; COVID-19; Case definition; Guidelines; Immunization; Pediatric.
Copyright © 2021 The Authors. Published by Elsevier Ltd.. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures
Similar articles
-
Multisystem inflammatory syndrome in children and adults (MIS-C/A): Case definition & guidelines for data collection, analysis, and presentation of immunization safety data.Vaccine. 2021 May 21;39(22):3037-3049. doi: 10.1016/j.vaccine.2021.01.054. Epub 2021 Feb 25. Vaccine. 2021. PMID: 33640145 Free PMC article. Review.
-
Vaccine-associated enhanced disease: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data.Vaccine. 2021 May 21;39(22):3053-3066. doi: 10.1016/j.vaccine.2021.01.055. Epub 2021 Feb 23. Vaccine. 2021. PMID: 33637387 Free PMC article. Review.
-
Anosmia: Brighton Collaboration case definition and guidelines for data collection, analysis, and presentation of immunization safety data.Vaccine. 2023 Mar 10;41(11):1902-1910. doi: 10.1016/j.vaccine.2022.11.022. Epub 2023 Feb 10. Vaccine. 2023. PMID: 36775774 Review.
-
Thrombosis and thromboembolism: Brighton collaboration case definition and guidelines for data collection, analysis, and presentation of immunization safety data.Vaccine. 2022 Oct 19;40(44):6431-6444. doi: 10.1016/j.vaccine.2022.09.001. Epub 2022 Sep 20. Vaccine. 2022. PMID: 36150973 Review.
-
Sensorineural hearing loss (SNHL) as an adverse event following immunization (AEFI): Case definition & guidelines for data collection, analysis, and presentation of immunization safety data.Vaccine. 2020 Jun 19;38(30):4717-4731. doi: 10.1016/j.vaccine.2020.05.019. Epub 2020 May 15. Vaccine. 2020. PMID: 32418788
Cited by
-
Acute Respiratory Distress Syndrome After Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV-2) Vaccination: Findings From an Autopsy.Cureus. 2024 Sep 28;16(9):e70370. doi: 10.7759/cureus.70370. eCollection 2024 Sep. Cureus. 2024. PMID: 39469356 Free PMC article.
-
Acute respiratory distress syndrome secondary to COVID-19 mRNA vaccine administration in a pregnant woman: A case report.Qatar Med J. 2022 Aug 9;2022(3):40. doi: 10.5339/qmj.2022.40. eCollection 2022. Qatar Med J. 2022. PMID: 35974885 Free PMC article.
-
Delayed inflammatory pulmonary syndrome: A distinct clinical entity in the spectrum of inflammatory syndromes in COVID-19 infection?World J Crit Care Med. 2023 Sep 9;12(4):226-235. doi: 10.5492/wjccm.v12.i4.226. eCollection 2023 Sep 9. World J Crit Care Med. 2023. PMID: 37745259 Free PMC article.
-
Developing standard safety outcomes for COVID-19 vaccines.Vaccine. 2021 May 21;39(22):3025-3027. doi: 10.1016/j.vaccine.2021.03.004. Epub 2021 Mar 12. Vaccine. 2021. PMID: 33888324 Free PMC article. No abstract available.
-
An autopsy case of COVID-19-like acute respiratory distress syndrome after mRNA-1273 SARS-CoV-2 vaccination.Int J Infect Dis. 2022 Aug;121:98-101. doi: 10.1016/j.ijid.2022.04.057. Epub 2022 Apr 30. Int J Infect Dis. 2022. PMID: 35500794 Free PMC article.
References
-
- Laennec R. A treatise on the diseases of the chest and on mediate auscultation. New York; Philadelphia: Samuel Wood & Sons; Desilver, Thomas & Co.; 1835.
-
- Ashbaugh DG, Bigelow DB, Petty TL, Levine BE, et al. Acute respiratory distress in adults. The Lancet, Saturday 12 August 1967. Crit Care Resusc, 2005;7(1):60–1. - PubMed
-
- Murray J.F., et al. An expanded definition of the adult respiratory distress syndrome. Am Rev Respir Dis. 1988;138(3):720–723. - PubMed
-
- Bernard GR et al. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med, 199149(3 Pt 1):818-24. - PubMed
-
- Ranieri V.M., et al. Acute respiratory distress syndrome: the Berlin Definition. JAMA. 2012;307(23):2526–2533. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous